Results 171 to 180 of about 530,938 (302)

Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze. [PDF]

Allergy Asthma Proc
Geyik C, Cansever M, Bektas F, Dorterler K, Saraymen B, Tahan F.   +5 more
europepmc   +1 more source

Interleukin-23 receptor signaling impairs the stability and function of colonic regulatory T cells. [PDF]

Cell Rep, 2023
Jacobse J, Brown RE, Li J, Pilat JM, Pham L, Short SP, Peek CT, Rolong A, Washington MK, Martinez-Barricarte R, Byndloss MX, Shelton C, Markle JG, Latour YL, Allaman MM, Cassat JE, Wilson KT, Choksi YA, Williams CS, Lau KS, Flynn CR, Casanova JL, Rings EHHM, Samsom JN, Goettel JA.   +24 more
europepmc   +1 more source

The role of Interleukin-23/Interleukin-17 axis in coexisting anti-glomerular basement membrane disease and lupus nephritis

, 2013
Jae Il Shin, SeJin Park, Ji Hong Kim, Tae‐Sun Ha   +3 more
openalex   +1 more source

Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy

Advanced Science, EarlyView.
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong, Yuhang Xie, Zhijie Weng, Yongzhi Wu, Longjiang Li, Bo Li   +5 more
wiley   +1 more source

Lichen planus onset during interleukin 23 blockade for treatment of psoriasis. [PDF]

JAAD Case Rep
Abbas A, Schroeder A, Elston C, Raman C, Elewski B.   +4 more
europepmc   +1 more source

Use of NanoBiT and NanoBRET to characterise interleukin-23 receptor dimer formation in living cells. [PDF]

Br J Pharmacol, 2023
Lay CS, Kilpatrick LE, Craggs PD, Hill SJ.   +3 more
europepmc   +1 more source

De Novo Design and Directed Evolution Refinement of Mirror‐Image Protein Binders Targeting Interleukin‐4

Advanced Science, EarlyView.
This study presents the de novo design and directed evolution of a mirror‐image D‐protein inhibitor targeting human interleukin‐4 (IL‐4). The engineered molecule exhibits nanomolar binding affinity for IL‐4 and effectively inhibits IL‐4–mediated signaling.
Liqing Xu, Yuxiang Ren, Tongyue Wang, Hongyong Li, Yue Yao, Lei Liu, Ke Sun, Peilong Lu   +7 more
wiley   +1 more source

Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan. [PDF]

Psoriasis (Auckl)
Xu Y, Li T, Chang CL, Zhang Y, Masuda J, Wu GH, Wahking B, Imafuku S, Qiu H.   +8 more
europepmc   +1 more source

Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis. [PDF]

J Neuroinflammation, 2023
Villegas JA, Van Wassenhove J, Merrheim J, Matta K, Hamadache S, Flaugère C, Pothin P, Truffault F, Hascoët S, Santelmo N, Alifano M, Berrih-Aknin S, le Panse R, Dragin N.   +13 more
europepmc   +1 more source

Effect of inhibition of interleukin-12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP-1 macrophages

, 2015
Iryna Voloshyna, Jessica S. Mounessa, Steven E. Carsons, Allison B. Reiss   +3 more
openalex   +2 more sources